Abstract
Background/Objectives: Nurses’ medical artificial intelligence (AI)-based innovative behavior may contribute to the effective application of medical AI in clinical practice and the improvement of nursing care. This study examined whether medical explainable artificial intelligence (XAI) was indirectly associated with nurses’ medical AI-based innovative behavior through trust in medical AI and whether medical AI information disclosure moderated the association between medical XAI and trust in medical AI. Methods: A two-wave time-lagged survey with a two-month interval was conducted among 389 nurses from three hospitals in Anhui Province, China. Medical XAI and medical AI information disclosure were measured at Wave 1, whereas trust in medical AI and medical AI-based innovative behavior were measured at Wave 2. Mediation, moderation, and moderated mediation analyses were conducted using Hayes’ PROCESS macro (Models 4 and 7) with 5000 bootstrap resamples. Results: Medical XAI was positively associated with trust in medical AI (B = 0.28, SE = 0.04, 95% CI [0.20, 0.36], p < 0.001), which, in turn, was positively associated with medical AI-based innovative behavior (B = 0.24, SE = 0.05, 95% CI [0.14, 0.34], p < 0.001). The indirect association through trust in medical AI was significant (B = 0.07, BootSE = 0.02, 95% bootstrap CI [0.03, 0.10]). Medical AI information disclosure moderated the association between medical XAI and trust in medical AI (B = 0.08, SE = 0.04, 95% CI [0.01, 0.16], p < 0.05). Specifically, this association was not significant at a low level of medical AI information disclosure (B = 0.04, SE = 0.06, 95% CI [−0.07, 0.16], p > 0.05) but was positive at a high level (B = 0.16, SE = 0.06, 95% CI [0.04, 0.27], p < 0.01). The index of moderated mediation was significant (index = 0.02, BootSE = 0.01, 95% bootstrap CI [0.01, 0.05]). Conclusions: These preliminary findings suggest that trust in medical AI may represent a link between medical XAI and nurses’ medical AI-based innovative behavior and that this indirect association may be stronger at higher levels of medical AI information disclosure. Although the findings should be interpreted as associations rather than causal evidence, they may offer initial insights for technology providers, hospital administrators, and medical institutions.